Susquehanna International Group
NMRD

Susquehanna International Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Susquehanna International Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-92,500
Closed -$404K – 14279
2022
Q1 		$404K Buy
92,500
+60,400
+188% +$253K ﹤0.01% 9525
2021
Q4 		$146K Buy
32,100
+3,700
+13% +$19.9K ﹤0.01% 11820
2021
Q3 		$171K Sell
28,400
-30,700
-52% -$221K ﹤0.01% 11661
2021
Q2 		$612K Buy
59,100
+23,300
+65% +$222K ﹤0.01% 9095
2021
Q1 		$274K Buy
+35,800
New +$237K ﹤0.01% 10794

Other funds holding NMRD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's NMRD Position: Q4 2023 in Review

Susquehanna International Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2023, closing a stake of 20,230 shares — an estimated $6.53K sold.

Susquehanna International Group first reported a position in NMRD in Q1 2018 and held it in 9 quarters. The position peaked at $273K in Q1 2022. 21 funds tracked by Wall St. Rank hold NMRD as of Q4 2023.

  • Susquehanna International Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 20,230 Nemaura Medical, Inc. Common Stock shares in Q4 2023, an estimated $6.53K.
  • Susquehanna International Group first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Susquehanna International Group's Nemaura Medical, Inc. Common Stock position peaked at $273K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.